These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14710532)

  • 21. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants.
    Gourion D; Goldberger C; Leroy S; Bourdel MC; Olié JP; Krebs MO
    Neuroreport; 2005 Aug; 16(12):1407-10. PubMed ID: 16056149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating the neurobiology of schizophrenia. Preface.
    Abi-Dargham A; Guillin O
    Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
    [No Abstract]   [Full Text] [Related]  

  • 24. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study.
    Jönsson EG; Edman-Ahlbom B; Sillén A; Gunnar A; Kulle B; Frigessi A; Vares M; Ekholm B; Wode-Helgodt B; Schumacher J; Cichon S; Agartz I; Sedvall GC; Hall H; Terenius L
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):924-33. PubMed ID: 16581172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia.
    Hirvonen J; van Erp TG; Huttunen J; Någren K; Huttunen M; Aalto S; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
    Psychiatry Res; 2006 Jan; 146(1):13-20. PubMed ID: 16361088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures.
    Takahashi T; Suzuki M; Tsunoda M; Kawamura Y; Takahashi N; Maeno N; Kawasaki Y; Zhou SY; Hagino H; Niu L; Tsuneki H; Kobayashi S; Sasaoka T; Seto H; Kurachi M; Ozaki N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1236-42. PubMed ID: 18472202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular genetics of cognitive deficit in schizophrenia].
    Golimbet VE
    Mol Biol (Mosk); 2008; 42(5):830-9. PubMed ID: 18988532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis use and schizophrenia.
    Krebs MO; Goldberger C; Dervaux A
    Am J Psychiatry; 2005 Feb; 162(2):401-2; author reply 402. PubMed ID: 15677615
    [No Abstract]   [Full Text] [Related]  

  • 30. Predictors of schizophrenia--a review.
    Mäki P; Veijola J; Jones PB; Murray GK; Koponen H; Tienari P; Miettunen J; Tanskanen P; Wahlberg KE; Koskinen J; Lauronen E; Isohanni M
    Br Med Bull; 2005; 73-74():1-15. PubMed ID: 15947217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Habit learning and the genetics of the dopamine D3 receptor: evidence from patients with schizophrenia and healthy controls.
    Kéri S; Juhász A; Rimanóczy A; Szekeres G; Kelemen O; Cimmer C; Szendi I; Benedek G; Janka Z
    Behav Neurosci; 2005 Jun; 119(3):687-93. PubMed ID: 15998189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential genetic variants in schizophrenia: a Bayesian analysis.
    Hall H; Lawyer G; Sillén A; Jönsson EG; Agartz I; Terenius L; Arnborg S
    World J Biol Psychiatry; 2007; 8(1):12-22. PubMed ID: 17366345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J; Makkai B; Gulyás B; Hall H
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia.
    Zai CC; Tiwari AK; De Luca V; Müller DJ; Bulgin N; Hwang R; Zai GC; King N; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Kennedy JL
    Eur Neuropsychopharmacol; 2009 May; 19(5):317-28. PubMed ID: 19217756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association between the Val66Met polymorphism of brain-derived neurotrophic factor gene and schizophrenia in Russians].
    Golimbet VE; Korovaĭtseva GI; Abramova LI; Kasparov SV; Uvarova LG
    Mol Biol (Mosk); 2008; 42(4):599-603. PubMed ID: 18856059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents.
    Newman AH; Grundt P; Nader MA
    J Med Chem; 2005 Jun; 48(11):3663-79. PubMed ID: 15916415
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression.
    Schumacher J; Jamra RA; Becker T; Ohlraun S; Klopp N; Binder EB; Schulze TG; Deschner M; Schmäl C; Höfels S; Zobel A; Illig T; Propping P; Holsboer F; Rietschel M; Nöthen MM; Cichon S
    Biol Psychiatry; 2005 Aug; 58(4):307-14. PubMed ID: 16005437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of the dopamine transporter-dopamine D2 receptor interaction in schizophrenia.
    Lee FJ; Pei L; Liu F
    Synapse; 2009 Aug; 63(8):710-2. PubMed ID: 19391151
    [No Abstract]   [Full Text] [Related]  

  • 39. Phenotype of schizophrenia: a review and formulation.
    Tamminga CA; Holcomb HH
    Mol Psychiatry; 2005 Jan; 10(1):27-39. PubMed ID: 15340352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.